Zobrazeno 1 - 10
of 10
pro vyhledávání: '"George Eisenbarth"'
Autor:
A. M. JAMES SHAPIRO, M. D, P.H. D, CAMILLO RICORDI, M. D, BERNHARD J. HERING, HUGH AUCHINCLOSS, ROBERT LINDBLAD, R. PAUL ROBERTSON, MATHIAS D. BRENDEL, THIERRY BERNEY, DANIEL C. BRENNAN, ENRICO CAGLIERO, RODOLFO ALEJANDRO, EDMOND A. RYAN, BARBARA DIMERCURIO, R. N, PHILIPPE MOREL, KENNETH S. POLONSKY, JO ANNA REEMS, P.H. D, REINHARD G. BRETZEL, FEDERICO BERTUZZI, TATIANA FROUD, RAJA KANDASWAMY, DAVID E. R. SUTHERLAND, GEORGE EISENBARTH, MIRIAM SEGAL, JUTTA PREIKSAITIS, GREGORY S. KORBUTT, FRANCA B. BARTON, M. S, LISA VIVIANO, VICKI SEYFERT MARGOLIS, JEFFREY BLUESTONE, AND JONATHAN R. T. LAKEY, P.H. D., SECCHI , ANTONIO
Background This international multicenter trial explores the feasibility and reproducibility of islet transplantation using a single common protocol (Edmonton Protocol ) for islet manufacture and post-transplant management. Methods A total of 36 subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::fe56908b8c53ae997cf449b56063cfb7
Autor:
Jay M, Sosenko, Jay S, Skyler, Jerry P, Palmer, Jeffrey P, Krischer, Liping, Yu, Jeffrey, Mahon, Craig A, Beam, David C, Boulware, Lisa, Rafkin, Desmond, Schatz, George, Eisenbarth, G, Treece
Publikováno v:
Diabetes Care
OBJECTIVE We assessed whether a risk score that incorporates levels of multiple islet autoantibodies could enhance the prediction of type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS TrialNet Natural History Study participants (n = 784) were tested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::899ea11dc98c21ce7e728e048ff3025e
https://pubmed.ncbi.nlm.nih.gov/23818528
https://pubmed.ncbi.nlm.nih.gov/23818528
Autor:
Georgia, Fousteri, Jean, Jasinski, Amy, Dave, Maki, Nakayama, Philippe, Pagni, Florence, Lambolez, Therese, Juntti, Ghanashyam, Sarikonda, Yang, Cheng, Michael, Croft, Hilde, Cheroutre, George, Eisenbarth, Matthias, von Herrath
Publikováno v:
Diabetes
In diabetic patients and susceptible mice, insulin is a targeted autoantigen. Insulin B chain 9-23 (B:9-23) autoreactive CD4 T cells are key for initiating autoimmune diabetes in NOD mice; however, little is known regarding their origin and function.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e8aae924380e79fc071b4fb5e33f66c
https://pubmed.ncbi.nlm.nih.gov/22403296
https://pubmed.ncbi.nlm.nih.gov/22403296
Publikováno v:
Novartis Foundation symposium. 292
Mucosal administration of autoantigen (insulin) to animal models has been demonstrated to be effective in preventing autoimmune diabetes. Efficacy is dependent upon the dose and the age at which it is delivered. Because of its low toxicity, mucosal a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6470eb7a0e730ff462e36c7494ed34e
https://pubmed.ncbi.nlm.nih.gov/19203100
https://pubmed.ncbi.nlm.nih.gov/19203100
Publikováno v:
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists. 11(2)
To report the clinical, biochemical, and immunologic characteristics of 7 white patients with the rare disorder of hyperinsulinemic hypoglycemia in association with spontaneously generated high titers of antibodies to human insulin.We reviewed the cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e178b70d19d066fbcb8daec954c7095
https://pubmed.ncbi.nlm.nih.gov/15901524
https://pubmed.ncbi.nlm.nih.gov/15901524
Autor:
Mustafa Aydintug, Li Zhang, Aaron Michels, Brian Day, George Eisenbarth, Rebecca O'Brien, Willi Born
Publikováno v:
The Journal of Immunology. 188:123.23-123.23
The insulin peptide ins2 B:9-23 is recognized by diabetogenic αβ T cells in NOD mice, and by γδ T cells. Unlike the αβ T cell response to the peptide, the γδ T cell response is independent of APCs. Furthermore, the cysteine residue in positio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::146a7cac693c8ce7018402f4b5c3a8e3
https://doi.org/10.4049/jimmunol.188.supp.123.23
https://doi.org/10.4049/jimmunol.188.supp.123.23
Publikováno v:
The Journal of Immunology. 184:83.8-83.8
Allogeneic mixed chimerim can prevent disease onset in Type 1 diabetes. While bone marrow (BM) allografts from MHC-mismatched donors can prevent disease in NOD mice, levels of mixed chimerism can be variable and unstable. Also, MHC-mismatched BM usua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e73b26422eb73b757337830be1ebf0e
https://doi.org/10.4049/jimmunol.184.supp.83.8
https://doi.org/10.4049/jimmunol.184.supp.83.8
Autor:
Edwin Liu, Marcella Li, Jean Jasinski, Masakazu Kobayashi, Roberto Gianani, Maki Nakayama, George Eisenbarth
Publikováno v:
Cell Biochemistry & Biophysics; Jun2007, Vol. 48 Issue 2/3, p177-182, 6p
Autor:
Evie Melanitou
Publikováno v:
Annals of the New York Academy of Sciences
Annals of the New York Academy of Sciences, 2005, Autoimmunity: Concepts and Diagnosis at the Cutting Edge 1050, pp.64-72. ⟨10.1196/annals.1313.008⟩
Annals of the New York Academy of Sciences, Wiley, 2005, Autoimmunity: Concepts and Diagnosis at the Cutting Edge 1050, pp.64-72. ⟨10.1196/annals.1313.008⟩
Annals of the New York Academy of Sciences, 2005, Autoimmunity: Concepts and Diagnosis at the Cutting Edge 1050, pp.64-72. ⟨10.1196/annals.1313.008⟩
Annals of the New York Academy of Sciences, Wiley, 2005, Autoimmunity: Concepts and Diagnosis at the Cutting Edge 1050, pp.64-72. ⟨10.1196/annals.1313.008⟩
International audience; The molecular mechanisms initiating the autoimmune process in type 1 diabetes mellitus (T1DM) remain unknown, and studies aiming to address this question have been compromised by the difficulty of predicting the disease at an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::465c4b04ae025b381caf2d9c41f07824
https://hal-pasteur.archives-ouvertes.fr/pasteur-01643745
https://hal-pasteur.archives-ouvertes.fr/pasteur-01643745